Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Christoffer Vannas"'
Autor:
Parmida Ranji, Emma Jonasson, Lisa Andersson, Stefan Filges, Manuel Luna Santamaría, Christoffer Vannas, Soheila Dolatabadi, Anna Gustafsson, Ola Myklebost, Joakim Håkansson, Henrik Fagman, Göran Landberg, Pierre Åman, Anders Ståhlberg
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background Myxoid liposarcoma (MLS) displays a distinctive tumor microenvironment and is characterized by the FUS::DDIT3 fusion oncogene, however, the precise functional contributions of these two elements remain enigmatic in tumor developme
Externí odkaz:
https://doaj.org/article/efac96b56a16441ab22d151be2064aa6
Autor:
Malin Lindén, Christoffer Vannas, Tobias Österlund, Lisa Andersson, Ayman Osman, Mandy Escobar, Henrik Fagman, Anders Ståhlberg, Pierre Åman
Publikováno v:
Molecular Oncology, Vol 16, Iss 13, Pp 2470-2495 (2022)
FET fusion oncoproteins containing one of the FET (FUS, EWSR1, TAF15) family proteins juxtaposed to alternative transcription‐factor partners are characteristic of more than 20 types of sarcoma and leukaemia. FET oncoproteins bind to the SWI/SNF ch
Externí odkaz:
https://doaj.org/article/3d44bdb19fd34f31bf7e193e0ead06e7
Autor:
Sara Bjursten, Christoffer Vannas, Stefan Filges, Florian Puls, Ankur Pandita, Henrik Fagman, Anders Ståhlberg, Max Levin
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 3, Pp 872-879 (2019)
Approximately 50% of patients with metastatic melanoma harbor an activating BRAF mutation. Tumors with activating mutation BRAF gene proliferate excessively and can be treated with targeted BRAF-inhibitors in combination with MEK inhibitors. The most
Externí odkaz:
https://doaj.org/article/4173e93fea8b411183872b332f9b3d19
Autor:
Christoffer Vannas, Lisa Andersson, Soheila Dolatabadi, Parmida Ranji, Malin Lindén, Emma Jonasson, Anders Ståhlberg, Henrik Fagman, Pierre Åman
Publikováno v:
Biomedicines, Vol 10, Iss 3, p 624 (2022)
The therapeutic options for patients with relapsed or metastatic myxoid liposarcoma (MLS) remain scarce and there is currently no targeted therapy available. Inhibition of the HSP90 family of chaperones has been suggested as a possible therapeutic op
Externí odkaz:
https://doaj.org/article/95925dd05c4c4d0aa3024bc338a99d8e
Autor:
Ayman Osman, Malin Lindén, Tobias Österlund, Christoffer Vannas, Lisa Andersson, Mandy Escobar, Anders Ståhlberg, Pierre Åman
Publikováno v:
Experimental cell research. 422(1)
DDIT3 is a tightly regulated basic leucine zipper (bZIP) transcription factor and key regulator in cellular stress responses. It is involved in a variety of pathological conditions and may cause cell cycle block and apoptosis. It is also implicated i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed9e0ed725de85c6ac3e6839c0fa38c5
https://pubmed.ncbi.nlm.nih.gov/36402425
https://pubmed.ncbi.nlm.nih.gov/36402425
Autor:
Florian Puls, Christoffer Vannas, Anders Ståhlberg, Stefan Filges, Max Levin, Ankur Pandita, Sara Bjursten, Henrik Fagman
Publikováno v:
Kompass Onkologie. 7:167-170
Rund 50 % aller Patienten mit metastasierendem Melanom haben eine aktivierende BRAF-Mutation. Tumoren mit aktivierender Mutation des BRAF-Gens proliferieren übermäßig und können zielgerichtet mit BRAF-Inhibitoren in Kombination mit MEK-Inhibitore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cbcc6216c00035042bdd717e9bcd8af
https://doi.org/10.1159/000510449
https://doi.org/10.1159/000510449
Autor:
null Malin Lindén, null Christoffer Vannas, null Tobias Österlund, null Lisa Andersson, null Ayman Osman, null Mandy Escobar, null Henrik Fagman, null Anders Ståhlberg, null Pierre Åman
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6800055bb799566b65387a6231e57a17
https://doi.org/10.1002/1878-0261.13195/v2/response1
https://doi.org/10.1002/1878-0261.13195/v2/response1
Autor:
Malin Lindén, Christoffer Vannas, Tobias Österlund, Lisa Andersson, Ayman Osman, Mandy Escobar, Henrik Fagman, Anders Ståhlberg, Pierre Åman
Publikováno v:
Molecular oncology. 16(13)
FET fusion oncoproteins containing one of the FET (FUS, EWSR1, TAF15) family proteins juxtaposed to alternative transcription-factor partners are characteristic of more than 20 types of sarcoma and leukaemia. FET oncoproteins bind to the SWI/SNF chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3f350747d9b34d2b49da309266ab8a6
https://pubmed.ncbi.nlm.nih.gov/35182012
https://pubmed.ncbi.nlm.nih.gov/35182012
Autor:
Florian Puls, Ankur Pandita, Henrik Fagman, Max Levin, Anders Ståhlberg, Stefan Filges, Christoffer Vannas, Sara Bjursten
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 3, Pp 872-879 (2019)
Approximately 50% of patients with metastatic melanoma harbor an activating BRAF mutation. Tumors with activating mutation BRAF gene proliferate excessively and can be treated with targeted BRAF-inhibitors in combination with MEK inhibitors. The most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6efb43f023f34a2989545ca3a7db2c7f
https://www.karger.com/Article/FullText/504291
https://www.karger.com/Article/FullText/504291
Autor:
Max Levin, Barbro Linderholm, Daniel Andersson, Stefan Filges, Helena Kristiansson, Gustav Johansson, Christoffer Vannas, Anders Ståhlberg, Tony E. Godfrey, Junrui Li
Publikováno v:
Clinical Cancer Research. 26:A23-A23
Novel diagnostic tools in oncology, prenatal diagnostics, and transplantation medicine depend on the detection of ultrarare variants. The analysis of cell-free DNA has the potential to revolutionize diagnosis, treatment monitoring, and recurrence and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a82cef0633514128070499266f1d6717
https://doi.org/10.1158/1557-3265.liqbiop20-a23
https://doi.org/10.1158/1557-3265.liqbiop20-a23